Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Ra Capital Management, L.P. sold 565,167 Werewolf Therapeutics, Inc. shares (Form 4)
Traded May 8 to May 12, 2026 · Filed May 12, 2026
From May 8 to May 12, 2026, Ra Capital Management, L.P. (10% owner) sold 565,167 Werewolf Therapeutics, Inc. shares at an average US$0.69 for US$391K, leaving 406,282 shares. Filed May 12, 2026 (Form 4).
- Sold
- 565,167 shares
- Price
- US$0.69 average (US$0.64 to US$0.71)
- Value
- US$391K
- Holding after
- 406,282 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Sale | 351,514 | US$0.71 | 5,885,968 | Indirect |
| May 8, 2026 | Common Stock | Sale | 25,012 | US$0.71 | 418,813 | Indirect |
| May 11, 2026 | Common Stock | Sale | 81,678 | US$0.67 | 5,804,290 | Indirect |
| May 11, 2026 | Common Stock | Sale | 5,812 | US$0.67 | 413,001 | Indirect |
| May 12, 2026 | Common Stock | Sale | 94,432 | US$0.64 | 5,709,858 | Indirect |
| May 12, 2026 | Common Stock | Sale | 6,719 | US$0.64 | 406,282 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Ra Capital Management, L.P.
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 16, 2026
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026